Velarion Records
Free. Unsubscribe any time.

Acumen Pharmaceuticals, Inc. (ABOS)

Acumen Pharmaceuticals, Inc. filed 29 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 7 reporting owners, covering 55 transactions and 412,494 shares. None carries the SEC's AFF10B5ONE flag; all 29 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Acumen Pharmaceuticals, Inc. 55

Adoption dates in Acumen Pharmaceuticals, Inc. 10

Results prints in Acumen Pharmaceuticals, Inc. 0

Trades before a print in Acumen Pharmaceuticals, Inc. 0

Interval to Acumen Pharmaceuticals, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Acumen Pharmaceuticals, Inc. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on September 3, 2024”

Sources: SEC EDGAR full-text search and the SEC submissions API.